![Michael Bumby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bumby
Finanzdirektor/CFO bei
XORTX THERAPEUTICS INC.
Vermögen: 26 282 $ am 31.05.2026
Profil
Michael Bumby is the founder of Bluenose & Co., founded in 2013.
Dr. Bumby is currently Director at reBOOT Canada since 2013, Director at MediPharm Labs Corp.
starting 2026, Chief Financial Officer at Trimel Biopharma, Inc. since 2015, and Chief Financial Officer at XORTX Therapeutics, Inc. since 2024.
Former positions include Director-Finance & Investment Banking at Eli Lilly & Co. from 2000 to 2011, Independent Director at MediPharm Labs Corp.
from 2023 to 2025, Chief Financial Officer at Merus Labs, Inc. from 2016 to 2017, Chief Financial Officer & Secretary at VIVO Cannabis, Inc. from 2021 to 2023, Chief Financial Officer & Head-Investor Relations at Antibe Therapeutics, Inc. from 2013 to 2015, Chief Financial Officer at Acerus Pharmaceuticals Corp.
from 2015 to 2016, Chief Financial Officer & Investor Contact at Merus Labs International, Inc., and Chief Financial Officer at Antibe Holdings, Inc. from 2012 to 2015.
Education includes a doctorate from the University of Guelph and an MBA from the University of Toronto.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDIPHARM LABS CORP. 0.11% | 01.01.2026 | 461’092 ( 0.11% ) | 26 282 $ | 31.05.2026 |
| 19.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Michael Bumby
| Unternehmen | Position | Beginn |
|---|---|---|
| XORTX THERAPEUTICS INC. | Finanzdirektor/CFO | 19.12.2024 |
| MEDIPHARM LABS CORP. | Direktor/Vorstandsmitglied | 01.01.2026 |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Finanzdirektor/CFO | 03.08.2015 |
reBOOT Canada | Direktor/Vorstandsmitglied | 01.09.2013 |
Ehemalige bekannte Positionen von Michael Bumby
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIPHARM LABS CORP. | Direktor/Vorstandsmitglied | 17.06.2025 |
| VIVO CANNABIS INC. | Finanzdirektor/CFO | 01.04.2023 |
Merus Labs, Inc.
 Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | 01.01.2017 |
| ACERUS PHARMACEUTICALS CORPORATION | Finanzdirektor/CFO | 01.06.2016 |
| ANTIBE THERAPEUTICS INC. | Finanzdirektor/CFO | 01.08.2015 |
Ausbildung von Michael Bumby
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus Labs, Inc.
Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Antibe Therapeutics, Inc.
 Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Trimel Biopharma, Inc.
Trimel Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
reBOOT Canada | |
Bluenose & Co. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MediPharm Labs Corp.
 MediPharm Labs Corp. Agricultural Commodities/MillingProcess Industries Engages in the pharmaceutical grade production of cannabis oil products | Process Industries |
Wählen Sie MarketScreener 
